ZARA, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.539
EU - Europa 1.288
AS - Asia 719
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 1
Totale 3.564
Nazione #
US - Stati Uniti d'America 1.523
CN - Cina 684
IE - Irlanda 338
IT - Italia 240
UA - Ucraina 223
FI - Finlandia 152
DE - Germania 115
GB - Regno Unito 75
SE - Svezia 65
FR - Francia 43
BE - Belgio 26
CA - Canada 16
IN - India 15
IR - Iran 9
EU - Europa 5
AU - Australia 4
NG - Nigeria 4
SG - Singapore 4
CH - Svizzera 3
JP - Giappone 3
MU - Mauritius 3
NL - Olanda 3
CZ - Repubblica Ceca 2
RU - Federazione Russa 2
BR - Brasile 1
DK - Danimarca 1
HK - Hong Kong 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 3.564
Città #
Chandler 377
Dublin 338
Jacksonville 268
Nanjing 188
Ashburn 127
Ann Arbor 104
Beijing 94
Nanchang 72
Wilmington 72
Shenyang 58
Medford 55
Princeton 55
Lawrence 54
Hebei 51
Helsinki 47
Jiaxing 45
Changsha 37
Milan 37
Pavia 37
Tianjin 37
Boardman 36
Shanghai 34
Hangzhou 29
Brussels 25
Woodbridge 23
Rome 19
Verona 18
Trieste 13
Washington 13
Bergamo 12
Los Angeles 12
Auburn Hills 11
Toronto 11
Palermo 10
Florence 8
Turin 7
Fairfield 6
New York 6
Norwalk 6
Dearborn 5
Jinan 5
Kunming 5
Ottawa 5
Zhengzhou 5
Como 4
Des Moines 4
Edinburgh 4
Guangzhou 4
Pune 4
Sacramento 4
Delhi 3
Mariglianella 3
Ningbo 3
Piscataway 3
Prato 3
Saluzzo 3
Sydney 3
Tokyo 3
Zurich 3
Bangalore 2
Bologna 2
Brembate di Sopra 2
Brno 2
Catania 2
Chicago 2
Cornate d'Adda 2
Ibadan 2
Kashan 2
Lanzhou 2
Lodi 2
San Francisco 2
San Possidonio 2
Seattle 2
Taizhou 2
Tappahannock 2
Treviglio 2
Udine 2
Zanjan 2
Albino 1
Almaty 1
Amsterdam 1
Andover 1
Ballabio 1
Berlin 1
Bloomfield 1
Borås 1
Canberra 1
Capriate San Gervasio 1
Cesena 1
Changchun 1
Christchurch 1
Collecorvino 1
Dallas 1
Geislingen an der Steige 1
Haikou 1
Houston 1
Huizen 1
Kavir 1
Lagos 1
Leawood 1
Totale 2.588
Nome #
Mapping the human genetic architecture of COVID-19 127
Klebsiella oxytoca e Citrobacter koseri ESbL- e VIM-produttori in un paziente in riabilitazione cardiologica: caso clinico 98
Valutazione del sistema BD ProbeTec ET per la diagnosi rapida di Mycobacterium tuberculosis complex 96
Resistenza mediata da metallo-Beta-lattamasi in P. aeruginosa in una struttura riabilitativa 96
Sensibilità in vitro al fluconazolo di isolati vaginali di Candida spp. 90
Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. 86
Assessment of a rapid molecular method for the identification of Mycobacterium tuberculosis 80
Evaluation of the LIPA assay in clinical Mycobacterium tuberculosis specimens 79
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals are Uniformly Susceptible to Benzothiazinones 74
Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007 73
Correlation between human immunodeficiencyvirus type 1 levels and cytokine profile into thecervicovaginal secretions of a female cohort 73
Prevalence of human papillomavirus genotypes in cervical samples from HIV-infected women 73
HIV Shedding in Cervico-Vaginal Secretions in Pregnant Women. 72
Prevalence and sensitivity profile to 5 antifungalagents of yeast species causing onychomycosis and vaginitis 72
Coesistenza di Klebsiella pneumoniae ed Escherichia coli kpc-3-produttori in una paziente in terapia intensiva. 69
Prevalence of human papillomavirus types in cervical samples from HIV-infected women 68
Characterisation of Mycobacterium tuberculosis populations during chronic infection: an Italian longitudinal study 68
In vitro activity of ceftaroline against a collection of hospital-acquired MRSA (ha-MRSA) and ha-MSSA italian isolates. 68
EVALUATION OF HIV-RELATED ACIDS AND PAPILLOMAVIRUS DNA IN CERVICOVAGINAL SECRETIONS OF HIV-POSITIVE WOMEN. 68
Per-type beta-lactamase-producing Proteus Mirabilis strains causing otubreaks in a general hospital in northern Italy 67
Nosocomial infections caused by pseudomonas aeruginosa with acquired blaVIM metallo-beta-lactamase genes in a hospital of Northern Italy 66
Immunogenicity of hepatitis A-inactivated vaccine administered to seronegative infants, and serological follow-up 12 months after second dose. 66
mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis 64
Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient at Cardiological Rehabilitation ward 64
CERVICAL INTRAEPITHELIAL NEOPLASIA AND CERVICOVAGINAL SHEDDING OF HUMAN IMMUNODEFICIENCY VIRUS. 62
The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions 62
Influence of lingual bracket position on microbial and periodontal parameters in vivo. 62
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 61
STUDIO MOLECOLARE DELLE FARMACORESISTENZE DI Mycobacterium tuberculosis IN CAMPIONI RESPIRATORI 61
Detection of ESBL-producing Gram-negative bacteria from surface and ground-waters in the Po Valley 61
A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria 59
Relazione tra acidi nucleici di HIV e HPV-DNA nelle secrezioni cervico-vaginali di donne HIV-1 sieropositive 58
Transfusion-transmitted virus infection in HIV-1-seropositive patients 57
Presenza di Escherichia coli ST131, ST3680, ST3681 KPC produttori in differenti strutture del nord Italia. 57
METODI PER LA EVIDENZIAZIONE DI METALLO-B-LATTAMASI IN PSEUDOMONAS AERUGINOSA RESISTENTE AI CARBAPENEMICI 56
Evaluation of the in vitro activity of ceftaroline and its potential against a collection of hospital-acquired methicillin-resistant Staphylococcus aureus and hospital-acquired methicillin-susceptible Staphylococcus aureus isolates recovered from various clinical samples 56
Antibiotic Resistance inEnterobacteriaceae UTI’s Isolates: An Update from the Northern Italy Community 55
Valutazione di due metodi commerciali per la diagnosi rapida di Mycobacterium tuberculosis complex in campioni clinici 54
DECLINE OF MATERNAL HAV ANTIBODIES IN NEONATAL COHORT. 54
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 53
RILEVAZIONE MOLECOLARE DELLE RESISTENZE DI MYCOBACTERIUM TUBERCULOSIS IN CAMPIONI CLINICI 52
Micosi disseminate da funghi unicellulari nel periodo 2003-2007 52
Synthesis and evaluation of α-ketotriazoles and α,β-diketotriazoles as inhibitors of Mycobacterium tuberculosis 52
Caratterizzazione di β-lattamasi a spettro esteso (ESβL) prodotte da isolati clinici di Pseudomonas Aeruginosa ceftazidime-resistenti 52
Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women 51
The influence of human immunodeficiency virus infection on Langerhans cell counts in the normal cervical tissue. 51
Occurrence of extended spectrum β-lactamases, KPC-Type, and MCR-1.2-producing enterobacteriaceae from wells, river water, and wastewater treatment plants in Oltrepò Pavese area, Northern Italy 51
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 51
Viral excretion in the cervicovaginal secretions of HIV-1 infected women receiving antiretroviral therapy. 49
Prevalence and antifungal susceptibility patternsof yeasts from women with vulvovaginitis 49
Low-dose combined oral contraceptive and cervicovaginal shedding of human immunodeficiency virus. 47
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 44
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients 43
Markers of local immunity in cervico-vaginal secretions of HIV-infected women: implications for HIV shedding. 43
Immunogeneticity of an anti-HAV vaccine in infants. 42
Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection 42
PREVALENZA DI B-LATTAMASI A SPETTRO ESTESO DI TIPO TEM E PER-1 IN ISOLATI CLINICI DI PROTEUS MIRABILIS IN UN OSPEDALE DEL NORD ITALIA 41
Totale 3.597
Categoria #
all - tutte 11.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020837 220 308 7 41 3 45 9 50 9 85 55 5
2020/2021396 48 46 10 43 3 49 6 55 10 60 54 12
2021/2022303 11 4 10 11 4 10 8 17 16 10 57 145
2022/20231.088 94 89 4 177 107 111 0 61 399 7 22 17
2023/2024387 44 57 18 27 41 69 16 24 1 20 20 50
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 3.597